Safety of sodium-glucose co-transporter 2 inhibitors during Ramadan fasting: Evidence, perceptions and guidelines

Safety of sodium-glucose co-transporter 2 inhibitors during Ramadan fasting: Evidence, perceptions and guidelines

<span style="color: black; mso-ascii-font-family: 'Times New Roman'; mso-ascii-theme-font: major-bidi; mso-hansi-font-family: 'Times New Roman'; mso-hansi-theme-font: major-bidi; mso-bidi-font-family: 'Times New Roman'; mso-bidi-theme-font: major-bidi;">...

Full description

Bibliographic Details
Main Author: Salem A. Beshyah
Format: Article
Language:English
Published: Mashhad University of Medical Sciences 2016-06-01
Series:Journal of Fasting and Health
Subjects:
SGLT2 inhibitor
Type 2 diabetes mellitus Type 1 diabetes
Canagliflozin
Dapagliflozin
Empagliflozin
Non-glycemic benefit of SGLT2 inhibitors
blood pressure
Elderly
Dehydration
Diuretics
Volume depletion
Ketoacidosis
Ramadan fasting
Ethnicity
Online Access:http://jnfh.mums.ac.ir/article_7099_9b9c0919d833be58926f4db116a7a843.pdf

Internet

http://jnfh.mums.ac.ir/article_7099_9b9c0919d833be58926f4db116a7a843.pdf

Similar Items